These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 17203725)

  • 21. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.
    Salmaso S; Mastrantonio P; Tozzi AE; Stefanelli P; Anemona A; Ciofi degli Atti ML; Giammanco A;
    Pediatrics; 2001 Nov; 108(5):E81. PubMed ID: 11694665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Australian vaccine preventable disease epidemiological review series: pertussis, 2006-2012.
    Pillsbury A; Quinn HE; McIntyre PB
    Commun Dis Intell Q Rep; 2014 Sep; 38(3):E179-94. PubMed ID: 25391404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of a pertussis booster vaccination program in adolescents and adults on the epidemiology of pertussis in Austria.
    Rendi-Wagner P; Paulke-Korinek M; Stanek G; Khanakah G; Kollaritsch H
    Pediatr Infect Dis J; 2007 Sep; 26(9):806-10. PubMed ID: 17721375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Monitoring of a whooping cough epidemic 1994/95 in Switzerland using the sentinel notification system. Sentinella Registry].
    Matter HC; Schmidt-Schläpfer G; Zimmermann H
    Schweiz Med Wochenschr; 1996 Aug; 126(34):1423-32. PubMed ID: 8848704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pertussis--United States, 1997-2000.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Feb; 51(4):73-6. PubMed ID: 11837909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of acellular pertussis vaccination during childhood (<7 years of age) for preventing pertussis in household contacts 1-9 years old in Catalonia and Navarra (Spain).
    Plans P; Toledo D; Sala MR; Camps N; Villanova M; Rodríguez R; Alvarez J; Solano R; García-Cenoz M; Barrabeig I; Godoy P; Minguell S
    Eur J Clin Microbiol Infect Dis; 2016 Dec; 35(12):2059-2067. PubMed ID: 27612470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pertussis in infants under one year old: risk markers and vaccination status--a case-control study.
    Zamir CS; Dahan DB; Shoob H
    Vaccine; 2015 Apr; 33(17):2073-8. PubMed ID: 25728322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of pertussis vaccination in New South Wales, Australia, 1996-1998.
    Torvaldsen S; Simpson JM; McIntyre PB
    Eur J Epidemiol; 2003; 18(1):63-9. PubMed ID: 12705625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pertussis vaccination in infancy lowers the incidence of pertussis disease and the rate of hospitalisation after one and two doses: analyses of 10 years of pertussis surveillance.
    Nilsson L; Lepp T; von Segebaden K; Hallander H; Gustafsson L
    Vaccine; 2012 May; 30(21):3239-47. PubMed ID: 22094282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A modelling analysis of pertussis transmission and vaccination in Rio de Janeiro, Brazil.
    Luz PM; Codeço CT; Werneck GL; Struchiner CJ
    Epidemiol Infect; 2006 Aug; 134(4):850-62. PubMed ID: 16316489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surveillance of infant pertussis in Sweden 1998-2012; severity of disease in relation to the national vaccination programme.
    Carlsson RM; von Segebaden K; Bergstrom J; Kling AM; Nilsson L
    Euro Surveill; 2015 Feb; 20(6):. PubMed ID: 25695476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Challenges of interpreting epidemiologic surveillance pertussis data with changing diagnostic and immunization practices: the case of the state of São Paulo, Brazil.
    Fernandes EG; Sartori AMC; de Soárez PC; Carvalhanas TRMP; Rodrigues M; Novaes HMD
    BMC Infect Dis; 2018 Mar; 18(1):126. PubMed ID: 29534683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology of pertussis in two Ibero-American countries with different vaccination policies: lessons derived from different surveillance systems.
    Solano R; Masa-Calles J; Garib Z; Grullón P; Santiago SL; Brache A; Domínguez Á; Caylà JA
    BMC Public Health; 2016 Nov; 16(1):1178. PubMed ID: 27876021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pertussis in Poland in 2011.
    Paradowska-Stankiewicz I; Rudowska J
    Przegl Epidemiol; 2013; 67(2):199-201, 319-21. PubMed ID: 24040716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resurgence of pertussis in Europe.
    Celentano LP; Massari M; Paramatti D; Salmaso S; Tozzi AE;
    Pediatr Infect Dis J; 2005 Sep; 24(9):761-5. PubMed ID: 16148840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pertussis in Poland in 2014.
    Paradowska-Stankiewicz I; Rudowska J
    Przegl Epidemiol; 2016; 70(3):327-332. PubMed ID: 27851884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiological shift in the prevalence of pertussis in Taiwan: implications for pertussis vaccination.
    Lin YC; Yao SM; Yan JJ; Chen YY; Chiang CS; Wu HS; Li SY
    J Med Microbiol; 2007 Apr; 56(Pt 4):533-537. PubMed ID: 17374896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trends in Canadian infant pertussis hospitalizations in the pre- and post-acellular vaccine era, 1981-2016.
    Desai S; Schanzer DL; Silva A; Rotondo J; Squires SG
    Vaccine; 2018 Nov; 36(49):7568-7573. PubMed ID: 30392765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A change in vaccine efficacy and duration of protection explains recent rises in pertussis incidence in the United States.
    Gambhir M; Clark TA; Cauchemez S; Tartof SY; Swerdlow DL; Ferguson NM
    PLoS Comput Biol; 2015 Apr; 11(4):e1004138. PubMed ID: 25906150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experiences with acellular pertussis vaccine in Japan and epidemiology of pertussis.
    Kimura M; Kuno-Sakai H
    Tokai J Exp Clin Med; 1987 Dec; 12(5-6):263-73. PubMed ID: 3508651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.